Faculty Summaries
Elin R Sigurdson, MD, PhD
Elin R Sigurdson, MD, PhD
Professor

Publications

  • O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative. Clinical Colorectal Cancer. 2011 Jun;10(2):113-6.
  • Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol. 2010 Nov;17(11):2933-9.
  • Shaw CM, Zhu F, Lessin S, Sigurdson E. Effect of Body Mass Index on Overall Survival in Patients with Stage III Melanoma. Ann Surg Oncol. 2010 Feb;17:S111-S111.
  • Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient. Int J Cancer. 2010 Sep;127(5):1124-30.
  • Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of Cancer Surgery: Implications for Patient Access to Optimal Care. J Clin Oncol. 2009 Oct;27(28):4671-8.
  • Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):55-9.
  • Turaka A, Freedman GM, Li T, Anderson PR, Swaby R, Nicolaou N, Goldstein L, Sigurdson ER, Bleicher RJ. Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol. 2009 Jul 1;100(1):25-31.
  • Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009 Aug;209(2):180-7; quiz 294-5.
  • Freedman GM, Anderson P, Litwin S, Swaby R, Nicolaou N, Sigurdson E, Ma C, Watkins-Bruner D, Morrow M, Goldstein L. Five-year Results of a Phase II Study of Hypofractionated IMRT with an Incorporated Boost for Breast Cancer. Int J Radiat Oncol Biol Phys. 2009;75(3):S77-S77.
  • Landry JC, Catalano P, Cohen SJ, Staley C, Sigurdson E, Feng Y, Benson AB. Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204. Int J Radiat Oncol Biol Phys. 2009;75(3):S27-S28.
  • Konski A, Li TY, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 2009;74(1):55-9.
  • Abramowitz MC, Li T, Morrow M, Sigurdson ER, Anderson P, Nicolaou N, Freedman G. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation. Am J Clin Oncol. 2009 Feb;32(1):30-3.